Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565859 · ClinicalTrials.gov registry record · NA
Effects of an Educational Planetary Plate Graphic on Meat Consumption
A NA study of Diet, Food and Nutrition, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 957
- Enrollment target
- 1
- Study location
NCT05565859: Completed NA study of Diet, Food and Nutrition, sponsored by Stanford University.
NCT05565859 is a NA study of Diet, Food and Nutrition that has completed, run by Stanford University. The registered enrollment target is 957 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05565859, a NA study of Diet, Food and Nutrition, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 957 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this research was to determine if adding a plate graphic depicting the components of the Eat Lancet Planetary Health diet (Figure 1) to food labels in Stanford University dining halls would lead to dining hall patrons making dietary decisions that better resemble the Planetary Health diet in comparison to a no signage control group. The study hypothesis was that presenting students with a plate graphic featuring the healthy reference diet would decrease objective measures of the amount of meat taken and therefore the environmental impact of student meals.
Primary Outcome
Meat-dish weight adjusted for the number of people entering the dining hall.
Conditions Studied
Interventions
- BEHAVIORAL Planetary Health Plate signage
Study Locations (1)
California
- Florence Moore Dining Hall, Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 957 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2022-03-09 |
| Phase | NA |
What the finished NCT05565859 record still lists
NCT05565859 is an interventional study that assigns participants to a tested intervention. The registered 957 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Diet, Food and Nutrition appearing as the primary indexed condition, and to 1 intervention - of which Planetary Health Plate signage is the first listed.
NCT05565859 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05565859 about?
NCT05565859 is a clinical study titled "Effects of an Educational Planetary Plate Graphic on Meat Consumption". The objective of this research was to determine if adding a plate graphic depicting the components of the Eat Lancet Planetary Health diet (Figure 1) to food labels in Stanford University dining halls would lead to dining hall patrons making dietary decisions that better resemble the Planetary Healt...
What is the current status of trial NCT05565859?
This trial is currently completed. It is a NA study. The enrollment target is 957 participants. The study started on 2020-01-02. Estimated completion is 2022-03-09.
What conditions does trial NCT05565859 study?
This clinical trial studies the following conditions: Diet, Food and Nutrition.
What interventions are being tested in trial NCT05565859?
The interventions under investigation include: Planetary Health Plate signage (BEHAVIORAL).
Who is sponsoring clinical trial NCT05565859?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05565859 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet, Food and Nutrition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05565859's enrollment target sits among peer trials
957 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI